Concepedia
Statistics
Publications
9
Citations
1.1K
H-Index
Active since
2010
Affiliations
AstraZeneca (United Kingdom)(Current)
AstraZeneca (United States)
Dawn Baker is an author at AstraZeneca (United Kingdom) specializing in medicine, oncology, and molecular oncology.
Publications per year
2010–2016
AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family
Paul R. Gavine, Lorraine Mooney, Elaine Kilgour et al. · Cancer Research · 2012 · 499 citations
Medicine, Oncology, Pharmacology +16
Vascular Endothelial Growth Factor Receptors VEGFR-2 and VEGFR-3 Are Localized Primarily to the Vasculature in Human Primary Solid Cancers
Neil R. Smith, Dawn Baker, Neil H. James et al. · Clinical Cancer Research · 2010 · 237 citations · Full text
Medicine, Cancer Biology, Oncology +16
Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted Therapy
Neil R. Smith, Dawn Baker, Matthew R. Farren et al. · Clinical Cancer Research · 2013 · 136 citations · Full text
Medicine, Cancer Biology, Oncology +17
The Effect of VEGF-Targeted Therapy on Biomarker Expression in Sequential Tissue from Patients with Metastatic Clear Cell Renal Cancer
Kevin Sharpe, Grant D. Stewart, Alan Mackay et al. · Clinical Cancer Research · 2013 · 69 citations
MEDI0639: A Novel Therapeutic Antibody Targeting Dll4 Modulates Endothelial Cell Function and Angiogenesis <i>In Vivo</i>
David W. Jenkins, Sarah J. Ross, Margaret H. Veldman-Jones et al. · Molecular Cancer Therapeutics · 2012 · 51 citations
Medicine, Cancer Biology, Oncology +15
1–5 of 9